NL-OMON24304尚未招募不适用
Esophagectomy for patients with resectable esophageal cancer and cervical lymph node metastases
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Histologically proven squamous cell carcinoma, adenocarcinoma or undifferentiated carcinoma of the intrathoracic esophagus.
- •-Surgical resectable carcinoma (T1-4a, N0-3)
排除标准
- •- Distant metastases
- •- Inadequate pulmonary function disabling transthoracic resection
研究者
相似试验
招募中
2 期
ode study: 'Esophageal resection for patients with esophageal cancer and cervical lymph node metastases'esophageal cancer with cervical lymphnode metastasis100179901001799110017998NL-OMON44167Heelkunde, chirurgie20
进行中（未招募）
不适用
Healing of patients suffering from gastroesophageal reflux esophagitisgrade C-D according to Los Angeles classification after treatment with pantoprazole-magnesium dihydrate 80 mg o.d. in comparison topantoprazole-sodium sesquihydrate 40 mg o.d. over 4 or 8 weeks - Magnum IIGastroesophageal reflux esophagitisMedDRA version: 5.0Level: lltClassification code 10038263EUCTR2004-000492-33-LTALTANA Pharma AG800
进行中（未招募）
不适用
Healing of patients suffering from gastroesophageal reflux esophagitisgrade C-D according to Los Angeles classification after treatment with pantoprazole-magnesium dihydrate 80 mg o.d. in comparison topantoprazole-sodium sesquihydrate 40 mg o.d. over 4 or 8 weeksEUCTR2004-000492-33-LVALTANA Pharma AG800
进行中（未招募）
不适用
Healing of patients suffering from gastroesophageal reflux esophagitisgrade A-D according to Los Angeles classification after treatment with pantoprazole-magnesium dihydrate 80 mg o.d. in comparison topantoprazole-sodium sesquihydrate 40 mg o.d. over 4 or 8 weeksGastroesophageal reflux esophagitisMedDRA version: 5.0Level: lltClassification code 10038263EUCTR2004-000493-32-ATALTANA Pharma AG1,980
进行中（未招募）
不适用
Healing of patients suffering from gastroesophageal reflux esophagitisgrade C-D according to Los Angeles classification after treatment with pantoprazole-magnesium dihydrate 80 mg o.d. in comparison topantoprazole-sodium sesquihydrate 40 mg o.d. over 4 or 8 weeks - Magnum IIEUCTR2004-000492-33-HUALTANA Pharma AG800